The COVID-19 pandemic challenged researchers to discover life-saving treatments at an unprecedented pace. While these researchers rose to the occasion by discovering drugs faster than ever before, variants continue to challenge the world in addressing COVID-19. New innovations in computer-aided drug discovery tools could
MoreResearchers have long known that many drugs can make us feel down or even depressed and that, as we age,
MoreThere are many different factors and underlying health conditions that can affect energy levels from day to day, as well as
More[column]The U.S. Food and Drug Administration has approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after
More[column]The U.S. Food and Drug Administration has approved a new use of Gleevec (imatinib) to treat children newly diagnosed with
MoreThe U.S. Food and Drug Administration is alerting health care providers and patients of a voluntary nationwide recall of all
More[column]Novo Nordisk announced a unique partnership to form Team Novo Nordisk, a global sports team with more than 100 cyclists,
MoreSanofi (EURONEXT: SAN and NYSE: SNY) ranked third among twenty pharmaceutical companies on the 2012 Access to Medicine Index (ATM
More[column width=”360px” padding=”20px”]We are in the midst of third quarter earnings reports, and they show with stark detail what the
More[column width=”360px” padding=”20px”]The supercharged race to get new treatments into the lucrative market for treating rheumatoid arthritis (RA) appeared to
More